The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Single-photon Emission Computed Tomography (SPECT) Systems-Global Market Insights and Sales Trends 2024
Synopsis
Single-photon emission computed tomography (CT) is a radioisotope CT scan and belongs to the category of nuclear medicine. The imaging principle is a combination of radionuclide development and CT three-dimensional imaging technology, which can show the distribution of radioisotopes in different layers. SPECT detects ordinary gamma rays, using a radioactive isotope that emits single photons, the radionuclides produced by atomic reactors that emit single photons during decay.
The global Single-photon Emission Computed Tomography (SPECT) Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Single-photon Emission Computed Tomography (SPECT) Systems in various end use industries. The expanding demands from the Diagnostic Laboratories, Research Institutes, Hospitals and Others, are propelling Single-photon Emission Computed Tomography (SPECT) Systems market. Hybrid SPECT System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Standalone SPECT System segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Single-photon Emission Computed Tomography (SPECT) Systems market, driven by demand from China, the second largest economy with some signs of stabilising, the Single-photon Emission Computed Tomography (SPECT) Systems market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single-photon Emission Computed Tomography (SPECT) Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single-photon Emission Computed Tomography (SPECT) Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single-photon Emission Computed Tomography (SPECT) Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single-photon Emission Computed Tomography (SPECT) Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single-photon Emission Computed Tomography (SPECT) Systems covered in this report include GE Healthcare, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, Eli Lillyand Company, Bayer, Gamma Medica-Ideas Inc, Siemens Healthineers and Philips Healthcare, etc.
The global Single-photon Emission Computed Tomography (SPECT) Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Guerbet
Lantheus Medical Imaging
Daiichi Sankyo
Eli Lillyand Company
Bayer
Gamma Medica-Ideas Inc
Siemens Healthineers
Philips Healthcare
Toshiba Medical Systems Corporation
Neusoft Medical Systems
Global Single-photon Emission Computed Tomography (SPECT) Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single-photon Emission Computed Tomography (SPECT) Systems market, Segment by Type:
Hybrid SPECT System
Standalone SPECT System
Global Single-photon Emission Computed Tomography (SPECT) Systems market, by Application
Diagnostic Laboratories
Research Institutes
Hospitals
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single-photon Emission Computed Tomography (SPECT) Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Single-photon emission computed tomography (CT) is a radioisotope CT scan and belongs to the category of nuclear medicine. The imaging principle is a combination of radionuclide development and CT three-dimensional imaging technology, which can show the distribution of radioisotopes in different layers. SPECT detects ordinary gamma rays, using a radioactive isotope that emits single photons, the radionuclides produced by atomic reactors that emit single photons during decay.
The global Single-photon Emission Computed Tomography (SPECT) Systems market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Single-photon Emission Computed Tomography (SPECT) Systems in various end use industries. The expanding demands from the Diagnostic Laboratories, Research Institutes, Hospitals and Others, are propelling Single-photon Emission Computed Tomography (SPECT) Systems market. Hybrid SPECT System, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Standalone SPECT System segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Single-photon Emission Computed Tomography (SPECT) Systems market, driven by demand from China, the second largest economy with some signs of stabilising, the Single-photon Emission Computed Tomography (SPECT) Systems market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Single-photon Emission Computed Tomography (SPECT) Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Single-photon Emission Computed Tomography (SPECT) Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Single-photon Emission Computed Tomography (SPECT) Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Single-photon Emission Computed Tomography (SPECT) Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Single-photon Emission Computed Tomography (SPECT) Systems covered in this report include GE Healthcare, Guerbet, Lantheus Medical Imaging, Daiichi Sankyo, Eli Lillyand Company, Bayer, Gamma Medica-Ideas Inc, Siemens Healthineers and Philips Healthcare, etc.
The global Single-photon Emission Computed Tomography (SPECT) Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare
Guerbet
Lantheus Medical Imaging
Daiichi Sankyo
Eli Lillyand Company
Bayer
Gamma Medica-Ideas Inc
Siemens Healthineers
Philips Healthcare
Toshiba Medical Systems Corporation
Neusoft Medical Systems
Global Single-photon Emission Computed Tomography (SPECT) Systems market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single-photon Emission Computed Tomography (SPECT) Systems market, Segment by Type:
Hybrid SPECT System
Standalone SPECT System
Global Single-photon Emission Computed Tomography (SPECT) Systems market, by Application
Diagnostic Laboratories
Research Institutes
Hospitals
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Single-photon Emission Computed Tomography (SPECT) Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Single-photon Emission Computed Tomography (SPECT) Systems
1.1 Single-photon Emission Computed Tomography (SPECT) Systems Market Overview
1.1.1 Single-photon Emission Computed Tomography (SPECT) Systems Product Scope
1.1.2 Single-photon Emission Computed Tomography (SPECT) Systems Market Status and Outlook
1.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Region (2018-2029)
1.4 Global Single-photon Emission Computed Tomography (SPECT) Systems Historic Market Size by Region (2018-2023)
1.5 Global Single-photon Emission Computed Tomography (SPECT) Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Single-photon Emission Computed Tomography (SPECT) Systems Market Size (2018-2029)
1.6.1 North America Single-photon Emission Computed Tomography (SPECT) Systems Market Size (2018-2029)
1.6.2 Europe Single-photon Emission Computed Tomography (SPECT) Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems Market Size (2018-2029)
1.6.4 Latin America Single-photon Emission Computed Tomography (SPECT) Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems Market Size (2018-2029)
2 Single-photon Emission Computed Tomography (SPECT) Systems Market by Type
2.1 Introduction
2.1.1 Hybrid SPECT System
2.1.2 Standalone SPECT System
2.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Single-photon Emission Computed Tomography (SPECT) Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Type (2018-2029)
3 Single-photon Emission Computed Tomography (SPECT) Systems Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Laboratories
3.1.2 Research Institutes
3.1.3 Hospitals
3.1.4 Others
3.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Single-photon Emission Computed Tomography (SPECT) Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Single-photon Emission Computed Tomography (SPECT) Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Single-photon Emission Computed Tomography (SPECT) Systems Revenue Breakdown by Application (2018-2029)
4 Single-photon Emission Computed Tomography (SPECT) Systems Competition Analysis by Players
4.1 Global Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Single-photon Emission Computed Tomography (SPECT) Systems as of 2022)
4.3 Date of Key Players Enter into Single-photon Emission Computed Tomography (SPECT) Systems Market
4.4 Global Top Players Single-photon Emission Computed Tomography (SPECT) Systems Headquarters and Area Served
4.5 Key Players Single-photon Emission Computed Tomography (SPECT) Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Single-photon Emission Computed Tomography (SPECT) Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare
5.1.1 GE Healthcare Profile
5.1.2 GE Healthcare Main Business
5.1.3 GE Healthcare Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.1.4 GE Healthcare Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Recent Developments
5.2 Guerbet
5.2.1 Guerbet Profile
5.2.2 Guerbet Main Business
5.2.3 Guerbet Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.2.4 Guerbet Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.2.5 Guerbet Recent Developments
5.3 Lantheus Medical Imaging
5.3.1 Lantheus Medical Imaging Profile
5.3.2 Lantheus Medical Imaging Main Business
5.3.3 Lantheus Medical Imaging Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.3.4 Lantheus Medical Imaging Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.3.5 Daiichi Sankyo Recent Developments
5.4 Daiichi Sankyo
5.4.1 Daiichi Sankyo Profile
5.4.2 Daiichi Sankyo Main Business
5.4.3 Daiichi Sankyo Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.4.4 Daiichi Sankyo Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.4.5 Daiichi Sankyo Recent Developments
5.5 Eli Lillyand Company
5.5.1 Eli Lillyand Company Profile
5.5.2 Eli Lillyand Company Main Business
5.5.3 Eli Lillyand Company Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.5.4 Eli Lillyand Company Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lillyand Company Recent Developments
5.6 Bayer
5.6.1 Bayer Profile
5.6.2 Bayer Main Business
5.6.3 Bayer Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.6.4 Bayer Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.6.5 Bayer Recent Developments
5.7 Gamma Medica-Ideas Inc
5.7.1 Gamma Medica-Ideas Inc Profile
5.7.2 Gamma Medica-Ideas Inc Main Business
5.7.3 Gamma Medica-Ideas Inc Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.7.4 Gamma Medica-Ideas Inc Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.7.5 Gamma Medica-Ideas Inc Recent Developments
5.8 Siemens Healthineers
5.8.1 Siemens Healthineers Profile
5.8.2 Siemens Healthineers Main Business
5.8.3 Siemens Healthineers Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.8.4 Siemens Healthineers Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.8.5 Siemens Healthineers Recent Developments
5.9 Philips Healthcare
5.9.1 Philips Healthcare Profile
5.9.2 Philips Healthcare Main Business
5.9.3 Philips Healthcare Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.9.4 Philips Healthcare Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.9.5 Philips Healthcare Recent Developments
5.10 Toshiba Medical Systems Corporation
5.10.1 Toshiba Medical Systems Corporation Profile
5.10.2 Toshiba Medical Systems Corporation Main Business
5.10.3 Toshiba Medical Systems Corporation Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.10.4 Toshiba Medical Systems Corporation Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.10.5 Toshiba Medical Systems Corporation Recent Developments
5.11 Neusoft Medical Systems
5.11.1 Neusoft Medical Systems Profile
5.11.2 Neusoft Medical Systems Main Business
5.11.3 Neusoft Medical Systems Single-photon Emission Computed Tomography (SPECT) Systems Products, Services and Solutions
5.11.4 Neusoft Medical Systems Single-photon Emission Computed Tomography (SPECT) Systems Revenue (US$ Million) & (2018-2023)
5.11.5 Neusoft Medical Systems Recent Developments
6 North America
6.1 North America Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Single-photon Emission Computed Tomography (SPECT) Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Single-photon Emission Computed Tomography (SPECT) Systems Market Dynamics
11.1 Single-photon Emission Computed Tomography (SPECT) Systems Industry Trends
11.2 Single-photon Emission Computed Tomography (SPECT) Systems Market Drivers
11.3 Single-photon Emission Computed Tomography (SPECT) Systems Market Challenges
11.4 Single-photon Emission Computed Tomography (SPECT) Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
